Wednesday, March 30, 2016

Jazz Pharmaceuticals' rare liver disorder drug wins U.S. approval

March 30 (Reuters) - The U.S. Food and Drug Administration

has cleared Jazz Pharmaceuticals Plc's drug to treat a

rare kind of liver disease, making it the first treatment to win

U.S. approval for...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)